Suppression of NADPH oxidase 2 substantially restores glucose-induced dysfunction of pancreatic NIT-1 cells

Huiping Yuan1, Yonggang Lu, Xiuqing Huang

  • 1Peking University Fifth School of Clinical Medicine (Beijing Hospital), Beijing, China.

The FEBS Journal
|November 16, 2010
PubMed

Insights

Reactive oxygen species (ROS) generated by NADPH oxidase 2 (NOX2) contribute to type 2 diabetes by impairing pancreatic beta-cell function and insulin secretion. Reducing NOX2 levels can restore beta-cell function in high glucose conditions.

Area of Science:

  • Endocrinology
  • Cell Biology
  • Metabolic Disease Research

Background:

  • Type 2 diabetes is characterized by impaired insulin secretion and insulin resistance.
  • Excessive reactive oxygen species (ROS) generation is linked to glucose-induced beta-cell dysfunction.
  • The precise cellular mechanisms of ROS generation and their role in beta-cell dysfunction remain unclear.

Purpose of the Study:

  • To investigate the role of NADPH oxidase 2 (NOX2)-derived ROS in high glucose-induced pancreatic beta-cell dysfunction.
  • To elucidate the signaling pathways involved in NOX2-mediated beta-cell damage.

Main Methods:

  • Induction of diabetes in Sprague-Dawley rats using a high-fat diet.
  • In vitro studies using pancreatic NIT-1 cells exposed to high glucose concentrations.
  • Assessment of ROS generation, NOX2 expression, insulin secretion, and apoptosis.
  • Utilized siRNA to reduce NOX2 expression and investigated downstream signaling pathways including p38MAPK, p53, PTEN, JNK, AKT/PKB, FOXO1, and PDX1.

Main Results:

  • Diabetic rats exhibited hyperglycemia, elevated ROS, and reduced pancreatic insulin content.
  • High glucose increased ROS and NOX2 expression in NIT-1 cells.
  • NOX2 reduction via siRNA rescued glucose-induced insulin secretion and expression.
  • High glucose induced beta-cell apoptosis and dysfunction via p38MAPK, p53, PTEN-dependent JNK activation, and AKT inhibition, leading to altered FOXO1 and PDX1 translocation.

Conclusions:

  • NOX2-derived ROS play a critical role in high glucose-induced beta-cell dysfunction.
  • The mechanism involves PTEN-dependent JNK activation and AKT inhibition, impacting insulin expression and secretion.
  • Targeting NOX2 may offer a therapeutic strategy for type 2 diabetes.

Related Concept Videos

Glucose Homeostasis: Pancreatic Islets and Insulin Secretion01:27

Glucose Homeostasis: Pancreatic Islets and Insulin Secretion

The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are co-secreted in...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Hormones Regulating Blood Glucose01:16

Hormones Regulating Blood Glucose

Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Oral Hypoglycemic Agents: Glinides01:06

Oral Hypoglycemic Agents: Glinides

Repaglinide (Prandin) and Nateglinide (Starlix), known as glinides, are oral insulin secretagogues that stimulate insulin release from pancreatic β cells by closing the ATP-sensitive potassium channels (KATP channel). Repaglinide controls insulin release from pancreatic β cells by managing potassium efflux. It shares two binding sites with sulfonylureas and also has a unique site, indicating overlapping mechanisms of action. With a rapid onset and a 4-7 hour duration, it effectively manages...